v3 Template
S

Stramsen Biotech Inc.

Biotechnology/Pharmaceuticals ~380 employees
Founded
--
Employees (Est.)
~380
19 leaders known
Total Funding
$25.0M
Funding Rounds
1
Last Funding
2025-04-07

About Stramsen Biotech Inc.

Stramsen Biotech, Inc. is an innovative, venture-backed biotech company focused on transforming patient care through plant-based medicine development. Their mission is to revolutionize patient care with safer, more effective treatments by leveraging nature, aiming to become a household name in the pharmaceutical industry. They prioritize biopharmaceutical solutions that rival traditional pharmaceuticals with improved safety profiles and reduced side effects.

Products & Services

SBX 1052 - Controls/prevents enlargement of the prostate glands.
SBX 2021 - Controls/prevents proliferation and metastasis of various cancer cells.
SBX 2023 - Treats various forms of peripheral neuropathic disorders.
SBX 1977 - A wound healing drug with cell proliferation and strong antibacterial properties.
SBX 2048 - Controls HIV and improves immunity.
SBX 1988 - Controls diabetes.
SBX 2011 - Treats kidney infections and dissolves/breaks up gallstones.
SBX 1967 - Relieves bone/joint pains, treats bone/joint infections, and improves joint lubrication.

Specialties

Plant-based medicine development Medicines for infectious and noninfectious diseases Cancer treatment Cardiovascular disease management HIV control Wound healing Kidney disease treatment Diabetes control Arthritis treatment Neurological disorder treatment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Share Subscription Facility
T: -
FT: Share Subscription Facility
A: 25000000
MR: -
FA: $25 million
FAN: 25000000
D: 2025-04-07
FD: 2025-04-07
1 investors
Share Subscription Facility Latest
2025-04-07
$25.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

N

Nicole Greenberg

Assistant Manager

A

Amy A. Sledzik

Sales & Marketing Manager

K

Kelly Reimann

Finance Manager

J

Joe Meuth

Chairman of Board of Directors

H

Hamis Malebo

Chief Chemist

S

Sabina

Chief Medical Officer and Clinical Trials Specialist

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Stramsen Biotech Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Pharmaceuticals
Company Size
~380 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro